Regenovue Sub-Q is recommended for treatment of deep-sized to extremely severe wrinkles including nasolabial. This product also works best for cheek, chin, nose and jawline augmentation that require a thicker substance to fill.

Regenovue is a dermal hyaluronic acid- (HA)-based filler with the 100% cross-linked structure. Innovative patented technology of HA cross-linking is used in the production of Regenovue. The product has outstanding purity, which means a minimum concentration of BDDE-derived by-products. Regenovue fillers are characterized by high elasticity and viscosity thus providing their even distribution and a long-lasting aesthetic effect. Compact structure of the gel guarantees a constant injection pressure (uniform injection rate), which makes the procedure as comfortable and easy as possible both for the patient and the specialist.

Key Features:

• one of the lowest levels of residual BDDE among dermal fillers (<0.0015 IU/mg)
• long-lasting esthetic effect due to the high viscosity and elasticity of the filler
• painless and injury-free injection due to the finely-divided gel structure and the presence of lidocaine in the composition
• dense monophasic structure of the gel ensures its uniform distribution in the subcutaneous layers
• natural-looking effect
• the products contain HA of non-animal origin
• provides elasticity and moisture to the skin

Treatment areas

• facial volumisation (forehead, temples, malars, lower lid, chin, preauricular area, and jawline)
• reduction of deep wrinkles and folds (nasolabial folds, worry lines, frown lines, perioral and chin wrinkles)
• nose bridge/ridge improvement

Features of Regenovue Sub-Q Plus:

• Ingredients: HA 24mg/ml, Lidocaine 0.3%
• Injecting area: Lower subcutaneous
• Contents: 1x 1.1ml, 2 x 27G needles
• Duration: 12-18 months
• Shelf Life: 24 months
• With lidocaine: Yes